GI-311

N/A

Report date: 2025/01/26 15:41:19

Base Information

Drug NameGI-311

Drug Alias NameGI-311

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionImmunoglobulin E modulators

TargetsImmunoglobulin E

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGI Innovation Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHypersensitivity

Inactive IndicationsN/A

ATC CodeN/A